- Tytuł:
- Safety, Virologic Efficacy, and Pharmacokinetics of CT-P59, a Neutralizing Monoclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Protein: Two Randomized, Placebo-Controlled, Phase I Studies in Healthy Individuals and Patients With Mild SARS-CoV-2 Infection
- Autorzy:
- Źródło:
- In Clinical Therapeutics October 2021 43(10):1706-1727
Czasopismo naukowe